A detailed history of Met Life Investment Management, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 12,207 shares of TYRA stock, worth $170,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,207
Previous 12,207 -0.0%
Holding current value
$170,898
Previous $195,000 46.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$14.45 - $20.22 $65,097 - $91,091
4,505 Added 58.49%
12,207 $195,000
Q1 2024

May 14, 2024

BUY
$11.61 - $20.0 $89,420 - $154,040
7,702 New
7,702 $126,000
Q2 2023

Apr 29, 2024

BUY
$11.99 - $17.51 $92,346 - $134,862
7,702 New
7,702 $131,000
Q1 2023

May 09, 2024

BUY
$6.85 - $16.22 $52,758 - $124,926
7,702 New
7,702 $124 Million
Q1 2023

May 15, 2023

BUY
$6.85 - $16.22 $52,758 - $124,926
7,702 New
7,702 $123,000

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $588M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.